Pharmaceutical Commerce - May/June 2016

Dispense As Written

Demand for cryogenic logistics propels business growth

A raft of new therapies is generating renewed optimism for cancer care, but even as lower-cost biosimilars enter the market, cost is a crippling factor

Packaging designers continue the uphill battle for converting the US pharma industry to unit-dose, compliance-improving packaging

New IT data-science and visualization tools advance supply chain management

Policymakers look at alternative payment models in oncology

The SP channel continues to grow, with manufacturers looking for more control over access

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis

Pharma spends heavily to secure its supply chain, while politicians bring out the re-importation topic

Integrating copay programs with multichannel marketing

Healthcare Compliance Packaging Council (HCPC) award again goes to PCI Pharma Services

Ensuring Patient Access and Effective Drug Enforcement Act (S. 483) calls for better industry-government coordination

Greenphire highlights its support of patient recruitment and retention

Double-digit growth (12.2%) for the second year running

Novo Nordisk and Vetter Pharma announce groundbreakings

Labels will have a combination of reference-product and biosimilar-specific information

Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians

'Customer Experience Tracker' measures success in oncologist interactions